|
|
||||||||


* Department of Molecular Genetics and Biochemistry and Molecular Virology and Microbiology Graduate Program, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261;
Childrens Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; and
Departments of Medicine and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461
Granulomas, focal accumulations of immune cells, form in the lung during Mycobacterium tuberculosis infection. Chemokines, chemotactic cytokines, are logical candidates for inducing migration of T lymphocytes and monocytes to and within the lung. TNF influences chemokine expression in some models. TNF-deficient mice infected with M. tuberculosis are highly susceptible to disease, and granuloma formation is inhibited. Through in vitro assays, we demonstrate that neutralization of TNF in M. tuberculosis-infected macrophages led to a reduction in many inflammatory chemokines, such as C-C chemokine ligand 5, CXC ligand 9 (CXCL9), and CXCL10. In TNF-deficient mice, immune cells migrated to the lungs early after infection, but did not organize to form granulomas within the lung. Although chemokine expression, as measured in whole lung tissue, was not different, the expression of chemokines in the CD11b+ subset of cells isolated ex vivo from the lungs of TNF-deficient mice had reduced expression of C-C chemokine ligand 5, CXCL9, and CXCL10 at early time points after TNF neutralization. Local expression of CXCR3-binding chemokines within the lungs, as determined by in situ hybridization, was also affected by TNF. Therefore, TNF affects the expression of chemokines by macrophages in vitro and CD11b+ cells in vivo, which probably influences the local chemokine gradients and granuloma formation.
This article has been cited by other articles:
![]() |
D. Di Liberto, M. Locati, N. Caccamo, A. Vecchi, S. Meraviglia, A. Salerno, G. Sireci, M. Nebuloni, N. Caceres, P.-J. Cardona, et al. Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection J. Exp. Med., September 1, 2008; 205(9): 2075 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Welsh, A. N. Abbott, S.-A. Hwang, J. Indrigo, L. Y. Armitige, M. R. Blackburn, R. L. Hunter, and J. K. Actor A role for tumour necrosis factor-{alpha}, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response Microbiology, June 1, 2008; 154(6): 1813 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Chakravarty, G. Zhu, M. C. Tsai, V. P. Mohan, S. Marino, D. E. Kirschner, L. Huang, J. Flynn, and J. Chan Tumor Necrosis Factor Blockade in Chronic Murine Tuberculosis Enhances Granulomatous Inflammation and Disorganizes Granulomas in the Lungs Infect. Immun., March 1, 2008; 76(3): 916 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Newton, S. L. Mackie, A. R. Martineau, K. A. Wilkinson, B. Kampmann, C. Fisher, S. Dutta, M. Levin, R. J. Wilkinson, and G. Pasvol Reduction of Chemokine Secretion in Response to Mycobacteria in Infliximab-Treated Patients Clin. Vaccine Immunol., March 1, 2008; 15(3): 506 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Maglione, J. Xu, and J. Chan B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis J. Immunol., June 1, 2007; 178(11): 7222 - 7234. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Chakravarty, J. Xu, B. Lu, C. Gerard, J. Flynn, and J. Chan The Chemokine Receptor CXCR3 Attenuates the Control of Chronic Mycobacterium tuberculosis Infection in BALB/c Mice J. Immunol., February 1, 2007; 178(3): 1723 - 1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Lin, S. Pawar, A. Myers, A. Pegu, C. Fuhrman, T. A. Reinhart, S. V. Capuano, E. Klein, and J. L. Flynn Early Events in Mycobacterium tuberculosis Infection in Cynomolgus Macaques Infect. Immun., July 1, 2006; 74(7): 3790 - 3803. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sud, C. Bigbee, J. L. Flynn, and D. E. Kirschner Contribution of CD8+ T Cells to Control of Mycobacterium tuberculosis Infection J. Immunol., April 1, 2006; 176(7): 4296 - 4314. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Vermi, F. Facchetti, E. Riboldi, H. Heine, S. Scutera, S. Stornello, D. Ravarino, P. Cappello, M. Giovarelli, R. Badolato, et al. Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma Blood, January 15, 2006; 107(2): 454 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Smith, C. Nathan, and H. H. Peavy Progress and New Directions in Genetics of Tuberculosis: An NHLBI Working Group Report Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1491 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Page, A. E. Jedlicka, B. Fakheri, G. S. Noland, A. K. Kesavan, A. L. Scott, N. Kumar, and Y. C. Manabe Mycobacterium-Induced Potentiation of Type 1 Immune Responses and Protection against Malaria Are Host Specific Infect. Immun., December 1, 2005; 73(12): 8369 - 8380. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lazarevic, D. Nolt, and J. L. Flynn Long-Term Control of Mycobacterium tuberculosis Infection Is Mediated by Dynamic Immune Responses J. Immunol., July 15, 2005; 175(2): 1107 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Keane TNF-blocking agents and tuberculosis: new drugs illuminate an old topic Rheumatology, June 1, 2005; 44(6): 714 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Saunders, S. Tran, S. Ruuls, J. D. Sedgwick, H. Briscoe, and W. J. Britton Transmembrane TNF Is Sufficient to Initiate Cell Migration and Granuloma Formation and Provide Acute, but Not Long-Term, Control of Mycobacterium tuberculosis Infection J. Immunol., April 15, 2005; 174(8): 4852 - 4859. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Olleros, R. Guler, D. Vesin, R. Parapanov, G. Marchal, E. Martinez-Soria, N. Corazza, J.-C. Pache, C. Mueller, and I. Garcia Contribution of Transmembrane Tumor Necrosis Factor to Host Defense against Mycobacterium bovis Bacillus Calmette-Guerin and Mycobacterium tuberculosis Infections Am. J. Pathol., April 1, 2005; 166(4): 1109 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Scott Algood and J. L. Flynn CCR5-Deficient Mice Control Mycobacterium tuberculosis Infection despite Increased Pulmonary Lymphocytic Infiltration J. Immunol., September 1, 2004; 173(5): 3287 - 3296. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |